Hematopoietic Cell Transplantation, Version 3.2025, NCCN Clinical Practice Guidelines In Oncology

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Hematopoietic Cell Transplantation (HCT) provide expert, multidisciplinary recommendations for autologous and allogeneic HCT based on current evidence. The NCCN Guidelines focus on pretransplant recipient evaluation, hematopoietic cell mobilization, conditioning, and the diagnosis and management of graft-versus-host disease (GVHD), a common complication of allogeneic HCT that is associated with significant morbidity. This selection from the NCCN Guidelines for HCT focuses on the diagnosis, workup, and management of acute and chronic GVHD, as well as important supportive care considerations.

Authors

Institutions

Publication Details

Journal
Journal of the National Comprehensive Cancer Network
Published
2025-10-01
DOI
https://doi.org/10.6004/jnccn.2025.0047
Citations
5
Primary Topic
Hematopoietic Stem Cell Transplantation
Type
article
Field-Weighted Citation Impact
8.85
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hematopoietic Cell Transplantation, Version 3.2025, NCCN Clinical Practice Guidelines In Oncology

Javier Bolaños‐Meade, Jonathan E. Brammer, Lori S. Muffly, John Magenau et al.
5 citations
Journal of the National Comprehensive Cancer Network
Hematopoietic Stem Cell Transplantation
8.85
article

Hematopoietic Cell Transplantation, Version 3.2025, NCCN Clinical Practice Guidelines In Oncology

Javier Bolaños‐Meade, Jonathan E. Brammer, Lori S. Muffly, John Magenau, Varun Mittal, Mohamed Kharfan Dabaja, Brion Randolph, Marco Mielcarek, Hany Elmariah, Mitchell E. Horwitz, Jeffrey Topal, Omer Jamy, Yago L. Nieto, Vincent T. Ho, Caspian Oliai, Meredith Cowden, Jonathan A. Gutman, Alison W. Loren, Adetola A. Kassim, Jonathan Cruz Moreira, Rasmus T. Hoeg, Aaron C. Logan, Thomas Martin, Areej El‐Jawahri, Genovefa A. Papanicolaou, Dimitrios Tzachanis, Krishna Gundabolu, Cameron Ninos, Ryotaro Nakamura, Asya Varshavsky‐Yanovsky, Mark A. Schroeder, Katie Stehman, Lauren Lee, Antonio Di Stasi, Joseph A. Pidala, Jeffrey Tessier, Mariam Nawas, Frankie Jones, Christina Luszcak
article en
5 citations

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Hematopoietic Cell Transplantation (HCT) provide expert, multidisciplinary recommendations for autologous and allogeneic HCT based on current evidence. The NCCN Guidelines focus on pretransplant recipient evaluation, hematopoietic cell mobilization, conditioning, and the diagnosis and management of graft-versus-host disease (GVHD), a common complication of allogeneic HCT that is associated with significant morbidity. This selection from the NCCN Guidelines for HCT focuses on the diagnosis, workup, and management of acute and chronic GVHD, as well as important supportive care considerations.

Journal of the National Comprehensive Cancer NetworkVol. 23(10)
Fox Chase Cancer Center (US), Barnes-Jewish Hospital (US), City Of Hope National Medical Center (US), St. Jude Children's Research Hospital (US), Cleveland Clinic (US), Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA), Memorial Sloan Kettering Cancer Center (US), The University of Texas MD Anderson Cancer Center (US), University of Tennessee Health Science Center (US), Breast Cancer Research Foundation (US), Meredith College (US), University of Utah (US), The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US), UC San Diego Health System (US), Huntsman Cancer Institute (US), Cancer Institute (WIA) (IN), Susan Thompson Buffett Foundation (US), WinnMed (US), Yale Cancer Center (US), Moffitt Cancer Center (US), Massachusetts General Hospital (US), Fred Hutch Cancer Center (US), Southwestern Medical Center (US), Jewish Hospital (US), University of Wisconsin Carbone Cancer Center (US), Sidney Kimmel Cancer Center (US), University Hospitals Seidman Cancer Center (US), Duke Medical Center (US), University of Colorado Cancer Center (US), Dana-Farber Brigham Cancer Center (US), Smilow Cancer Hospital (US), UCSF Helen Diller Family Comprehensive Cancer Center (US), Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Moores Cancer Center, University of Chicago Medicine Comprehensive Cancer Center, UCLA Jonsson Comprehensive Cancer Center, Vanderbilt-Ingram Cancer Center, Stanford Cancer Institute, Duke Cancer Institute, Fred and Pamela Buffett Cancer Center, UC Davis Comprehensive Cancer Center, Harold C. Simmons Comprehensive Cancer Center, O'Neal Comprehensive Cancer Center, National Comprehensive Cancer Network, Indiana University (US), University of Pennsylvania (US), University of California, Davis (US), The University of Texas Southwestern Medical Center (US), University of Colorado Denver (US)
Openalex Percentile: Top 2%
Hematopoietic Stem Cell Transplantation
8.85
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.